Regen BioPharma Inc

Regen BioPharma Inc.’s stem cell-derived therapy, HemaXellerate, is poised to make a significant impact on the chemotherapy treatment market, potentially transforming treatment options for patients and redefining industry standards.

Regen BioPharma Inc. is a biotechnology company dedicated to developing innovative therapies for cancer and neurological disorders, with a mission to transform patients’ lives through scientific breakthroughs.